Lv61
2960 积分 2021-09-15 加入
A bispecific antibody targeting HER2 and PD-L1 inhibits tumor growth with superior efficacy
15天前
已完结
High-dose subcutaneous Administration of Biologics: Overcoming barriers through formulation and device innovation
1个月前
已完结
Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation
1个月前
已完结
Sacituzumab govitecan (IMMU‐132), an anti‐Trop‐2‐SN‐38 antibody‐drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics
1个月前
已完结
An anti–TNF–glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases
1个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
2个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
2个月前
已关闭
The Osmolality and Hemolysis of High-Concentration Monoclonal Antibody Formulations
3个月前
已完结
Non-ideal osmolality behavior in high-concentration protein formulations: mechanistic insights from freezing-point depression, vapor-pressure deficit, and molecular dynamics simulations
3个月前
已关闭
Considerations for Antibody-Drug Conjugate Design: Stability and Formulation
5个月前
已完结
皖公网安备34019202002308
